Characterization of the homo- and heterotypic immune responses after natural norovirus infection

Journal of Medical Virology

Volumn 77, Issue 3, 2005, Pages 439-446

  Rockx, Barry ^a,b   Baric, Ralph S ^b,c   De Grijs, Ingrid ^a   Duizer, Erwin ^a   Koopmans, Marion P G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody responses; Avidity; Blocking antibodies; NoV specific

Indexed keywords

ANTIBODY; CARBOHYDRATE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIGAND; NEUTRALIZING ANTIBODY; RNA POLYMERASE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; IMMUNE RESPONSE; NOROVIRUS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SEROPREVALENCE; SOUTHERN BLOTTING; VIRUS GENOME; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; CALICIVIRIDAE INFECTIONS; CROSS REACTIONS; DISEASE OUTBREAKS; GASTROENTERITIS; GENOTYPE; HUMANS; NETHERLANDS; NOROVIRUS; PREVALENCE;

NOROVIRUS;

EID: 25844495329     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20473     Document Type: Article

References (46)

1. Burton DR, Williamson RA, Parren PW. 2000. Antibody and virus: Binding and neutralization. Virology 270:1-3.
2. Cubitt WD, Green KY, Payment P. 1998. Prevalence of antibodies to the Hawaii strain of human calicivirus as measured by a recombinant protein based immunoassay. J Med Virol 54:135-139.
3. de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Vinje J, van Duynhoven YT. 2001a. Etiology of gastroenteritis in sentinel general practices in the netherlands. Clin Infect Dis 33:280-288.
4. de Wit MA, Koopmans MP, Kortbeek LM, Wannet WJ, Vinje J, van Leusden F, Bartelds AI, van Duynhoven YT. 2001b. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: Incidence and etiology. Am J Epidemiol 154:666-674.
5. Dingle KE, Lambden PR, Caul EO, Clarke IN. 1995. Human enteric Caliciviridae: The complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus. J Gen Virol 76:2349-2355.
6. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J Gen Virol 85:79-87.
7. Erdman DD, Gary GW, Anderson LJ. 1989. Serum immunoglobulin A response to Norwalk virus infection. J Clin Microbiol 27:1417-1418.
8. Farkas T, Thornton SA, Wilton N, Zhong W, Altaye M, Jiang X. 2003. Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. J Infect Dis 187:187-193.
9. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 31:2185-2191.
10. Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO, Nakata S, Neill JD, Studdert MJ, Thiel HJ. 2000. Taxonomy of the caliciviruses. J Infect Dis 181:3322-3330.
11. Gutierrez J, Maroto C. 1996. Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. Microbios 87:113-121.
12. Hale AD, Lewis DC, Jiang X, Brown DW. 1998. Homotypic and heterotypic IgG and IgM antibody responses in adults infected with small round structured viruses. J Med Virol 54:305-312.
13. Hale AD, Tanaka TN, Kitamoto N, Ciarlet M, Jiang X, Takeda N, Brown DW, Estes MK. 2000. Identification of an epitope common to genogroup 1 norwalk-like viruses. J Clin Microbiol 38:1656-1660.
14. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343.
15. Harrington PR, Vinje J, Moe CL, Baric RS. 2004. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J Virol 78:3035-3045.
16. Hedman K, Rousseau SA. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 27:288-292.
17. Hinkula J, Ball JM, Lofgren S, Estes MK, Svensson L. 1995. Antibody prevalence and immunoglobulin IgG subclass pattern to Norwalk virus in Sweden. J Med Virol 47:52-57.
18. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, Altaye M, Pickering LK, Newburg DS, LePendu J, Jiang X. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: Identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31.
19. Inouye S, Hasegawa A, Matsuno S, Katow S. 1984. Changes in antibody avidity after virus infections: Detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 20:525-529.
20. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66:6527-6532.
21. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB. 1990. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 161:18-21.
22. Kanno A, Kazuyama Y. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol 68:229-233.
23. Kitamoto N, Tanaka T, Natori K, Takeda N, Nakata S, Jiang X, Estes MK. 2002. Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol 40:2459-2465.
24. Koopmans M, Vinje J, Duizer E, de Wit M, van Duijnhoven Y. 2001. Molecular epidemiology of human enteric caliciviruses in The Netherlands. Novartis Found Symp 238:197-214; discussion 214-198.
25. Lee MS, Nokes DJ, Hsu HM, Lu CF. 2000. Protective titres of measles neutralising antibody. J Med Virol 62:511-517.
26. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548-553.
27. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torven M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szucs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. 2004. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363:682-688.
28. Madore HP, Treanor JJ, Buja R, Dolin R. 1990. Antigenic relatedness among the Norwalk-like agents by serum antibody rises. J Med Virol 32:96-101.
29. Noel JS, Ando T, Leite JP, Green KY, Dingle KE, Estes MK, Seto Y, Monroe SS, Glass RI. 1997. Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J Med Virol 53:372-383.
30. Parker SP, Cubitt WD, Jiang XJ, Estes MK. 1994. Seroprevalence studies using a recombinant Norwalk virus protein enzyme immunoassay. J Med Virol 42:146-150.
31. Parker SP, Cubitt WD, Jiang X. 1995. Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK. J Med Virol 46:194-200.
32. Parker TD, Kitamoto N, Tanaka T, Hutson AM, Estes MK. 2005. Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol 79:7402-7409.
33. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 297:86-89.
34. Reuter G, Krisztalovics K, Vennema H, Koopmans M, Szucs G. 2005. Evidence of the etiological predominance of norovirus in gastroenteritis outbreaks-emerging new-variant and recombinant noroviruses in Hungary. J Med Virol 76:598-607.
35. Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A. 2003. Measurement of EBV-IgG anti-VGA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol 70:617-623.
36. Rockx B, De Wit M, Vennema H, Vinje J, De Bruin E, Van Duynhoven Y, Koopmans M. 2002. Natural history of human calicivirus infection: A prospective cohort study. Clin Infect Dis 35:246-253.
37. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191:749-754.
38. Rohayem J, Munch J, Rethwilm A. 2005. Evidence of recombination in the norovirus capsid gene. J Virol 79:4977-4990.
39. Salonen EM, Hovi T, Meurman O, Vesikari T, Vaheri A. 1985. Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella. J Med Virol 16:1-9.
40. Sutter RW, Pallansch MA, Sawyer LA, Cochi SL, Hadler SC. 1995. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: Poliovirus vaccination. Ann N Y Acad Sci 754:289-299.
41. Treanor JJ, Jiang X, Madore HP, Estes MK. 1993. Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus. J Clin Microbiol 31:1630-1634.
42. Vinje J, Koopmans MP. 1996. Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. J Infect Dis 174:610-615.
43. Vinje J, Altena SA, Koopmans MP. 1997. The incidence and genetic variability of small round-structured viruses in outbreaks of gastroenteritis in The Netherlands. J Infect Dis 176:1374-1378.
44. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. 1974. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 129:709-714.
45. Yoda T, Terano Y, Suzuki Y, Yamazaki K, Oishi I, Utagawa E, Shimada A, Matsuura S, Nakajima M, Shibata T. 2000. Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli. Microbiol Immunol 44:905-914.
46. Yoda T, Suzuki Y, Terano Y, Yamazaki K, Sakon N, Kuzuguchi T, Oda H, Tsukamoto T. 2003. Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J Clin Microbiol 41:2367-2371.